Oncternal Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oncternal Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2019 to Q3 2024.
  • Oncternal Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $154K, a 47.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $154K -$137K -47.1% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $190K -$176K -48.1% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $225K +$175K +350% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $258K +$171K +197% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $291K +$169K +139% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $366K +$209K +133% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $50K +$19K +61.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $87K +$12K +16% Dec 31, 2022 10-K 2024-03-07
Q3 2022 $122K +$3K +2.52% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $157K -$5K -3.09% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $31K -$173K -84.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $75K +$35K +87.5% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $119K +$40K +50.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $162K +$45K +38.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $204K +$50K +32.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $40K -$150K -78.9% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $79K -$147K -65% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $117K -$148K -55.8% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $154K Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $190K Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 $226K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $265K Jun 30, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.